close
MENU
Hot Topic EARNINGS
How to guide
How to guide
Home
NBR Marketplace
The NBR List
NBR Video

Categories

General Business Investment Economics Te Ao Māori Politics Infrastructure Australia Tech & Innovation Finance Law Professional Services Primary Industries Retail Property Deals Aviation News Comings & Goings

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

Podcasts Audio Articles Entrepreneurs Your Business Beehive Banter Morning Brew Toil & Trouble NZ Aviation News Back Issues Market Outlook Dollars & Sense Private Bin Opinion (Archive) NBR Radar (Archive) NBR Rich List (Archive)
Hot Topic EARNINGS
Investment
3 mins to read

AFT wins latest skirmish in battle over potential Pascomer profit

The decision foreshadowed an appeal hearing over a High Court ruling that neither party were satisfied with.

AFT clinical trials.

Fiona Rotherham Thu, 20 Feb 2025

The Court of Appeal has rejected an attempt by PBL Solutions to slip in a further expert opinion ahead of an appeal hearing relating to a row with listed AFT Pharmaceuticals over a drug under development.

Malaysia-based management consultancy PBL Solutions has appealed part of a High Court judgment

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
View terms and conditions.
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Smartphone Only Annual Subscription

NZ$249.00 / yearly

Monthly Premium Online Subscription

NZ$49.95 / monthly

Smartphone Only Subscription

NZ$29.95 / monthly

Premium Group Membership 10 Users

NZ$385+GST / monthly

$38.5 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$660+GST / monthly

$33 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1375+GST / monthly

$27.5 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$2100+GST / monthly

$21 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Fiona Rotherham Thu, 20 Feb 2025
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Tags
Pascomer PBLSolutions Court of Appeal
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Related News
Investment

AFT reports half-year loss despite top total sales
Investment

AFT’s Maxigesic IV to be made and sold in China
Investment
1

AFT ‘honestly wouldn’t entertain’ raise to outright purchase IP
Law

PBL to appeal part of AFT Pharma court ruling
General Business

Why Kiwi drug maker is not calling it quits on Pascomer
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Related News
Investment

AFT reports half-year loss despite top total sales
Investment

AFT’s Maxigesic IV to be made and sold in China
Investment
1

AFT ‘honestly wouldn’t entertain’ raise to outright purchase IP
Law

PBL to appeal part of AFT Pharma court ruling
General Business

Why Kiwi drug maker is not calling it quits on Pascomer
AFT wins latest skirmish in battle over potential Pascomer profit
Investment,
107899
true
Subscribe Login